Conference call scheduled for August 12, 2008 at 1:30 p.m. (Pacific);

                  simultaneous webcast at http://www.adventrx.com



    SAN DIEGO, Aug. 8 /EMWNews/ -- ADVENTRX Pharmaceuticals,

Inc. (Amex: ANX) today announced that it will host a conference call with

simultaneous webcast to discuss second quarter 2008 results on Tuesday,

August 12th, 2008 at 1:30 p.m. Pacific / 4:30 p.m. Eastern. Evan M. Levine,

Chief Executive Officer and President, and Mark N. K. Bagnall, Chief

Financial Officer and Executive Vice President, will host the conference

call.



    The conference call may be accessed by dialing (888) 215-7027 for

domestic callers and (913) 312-0654 for international callers. The webcast

will be available live via the Internet by accessing ADVENTRX's website at

http://www.adventrx.com under "Investors". Replays of the webcast will be

available on ADVENTRX's website for 30 days and a phone replay will be

available through September 12, 2008 by dialing (888) 203-1112 and entering

the pass code 8240633.

    About ADVENTRX Pharmaceuticals



    ADVENTRX Pharmaceuticals is a biopharmaceutical company focused on

in-licensing, developing and commercializing proprietary product candidates

primarily for the treatment of cancer and infectious disease. The Company

seeks to improve the performance and commercial potential of existing

treatments by addressing problems associated with these treatment regimens.

More information can be found on ADVENTRX's web site at

http://www.adventrx.com.